Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)

We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the ph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of veterinary pharmacology and therapeutics 2005-02, Vol.28 (1), p.21-27
Hauptverfasser: Maslow, J.N, Mikota, S.K, Zhu, M, Isaza, R, Peddie, L.R, Dunker, F, Peddie, J, Riddle, H, Peloquin, C.A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 27
container_issue 1
container_start_page 21
container_title Journal of veterinary pharmacology and therapeutics
container_volume 28
creator Maslow, J.N
Mikota, S.K
Zhu, M
Isaza, R
Peddie, L.R
Dunker, F
Peddie, J
Riddle, H
Peloquin, C.A
description We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the pharmacokinetics (PK) of isoniazid (INH) in elephants and provide suggestions regarding initial treatment regimens. Forty-one elephants received INH daily by either oral or rectal administration with different formulations. Population PK analysis was performed using Non-linear Mixed Effect Modeling (NONMEM). Results of oral administration indicated that compared with premixed INH solution, the drug exposure was highest with a suspension prepared freshly with INH powder. When INH was concomitantly given as an admixture over food, T(max) was delayed and variability in drug absorption was significantly increased. Compared with oral administration, similar drug exposures were found when INH was dosed rectally. The data generated suggest that a starting dose of 7.5 mg/kg of INH is appropriate for initial TB treatment in elephants when premixed solution is administered directly into the oropharynx or rectal vault and 4 mg/kg are when INH is administered following immediate suspension from powdered form.
doi_str_mv 10.1111/j.1365-2885.2004.00619.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67444772</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67444772</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4289-3ef2206019068ea0717ef7cb615475e550a050b960e9f7c876277ed2664300953</originalsourceid><addsrcrecordid>eNqNkcFu1DAQhiMEokvhFcAnBIcsYyeOE4nLqioFtEARtBwtJ5m03ib2Yjtil8fhSXE2q3LFF_-a-f4Zy3-SEApLGs-bzZJmBU9ZWfIlA8iXAAWtlrsHyeK-8TBZAM0hFaLMTpIn3m8AICspfZycUC4YcEoXyZ9Lux17FbQ1ZHur3KAae6cNBt14YjuivTVa_dYt0YaEWyTBoQoDmjB1P-0bW6smoNPjQMJYo2vG3nrtiRqsuSErr5UhyrRk1TndRI09xj0mePLq_CA9GdROD6M_YGu7s601QRE1G9Trp8mjTvUenx3v0-Tq3fn3s_fp-svFh7PVOm1yVlZphh1jUACtoChRgaACO9HUBeW54Mg5KOBQVwVgFeulKJgQ2LKiyDOAimenyct57tbZnyP6IAftG-x7ZdCOXhYiz3MhWATLGWyc9d5hJ7dOD8rtJQU55SM3copBTjHIKR95yEfuovX5ccdYD9j-Mx4DicDbGfile9z_92D58foyimhPZ7v2AXf3duXu4vMzweWPzxeyzKqvrMyEvI78i5nvlJXqxmkvr74xoNOPVDlnkP0Fyou4qA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67444772</pqid></control><display><type>article</type><title>Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Maslow, J.N ; Mikota, S.K ; Zhu, M ; Isaza, R ; Peddie, L.R ; Dunker, F ; Peddie, J ; Riddle, H ; Peloquin, C.A</creator><creatorcontrib>Maslow, J.N ; Mikota, S.K ; Zhu, M ; Isaza, R ; Peddie, L.R ; Dunker, F ; Peddie, J ; Riddle, H ; Peloquin, C.A</creatorcontrib><description>We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the pharmacokinetics (PK) of isoniazid (INH) in elephants and provide suggestions regarding initial treatment regimens. Forty-one elephants received INH daily by either oral or rectal administration with different formulations. Population PK analysis was performed using Non-linear Mixed Effect Modeling (NONMEM). Results of oral administration indicated that compared with premixed INH solution, the drug exposure was highest with a suspension prepared freshly with INH powder. When INH was concomitantly given as an admixture over food, T(max) was delayed and variability in drug absorption was significantly increased. Compared with oral administration, similar drug exposures were found when INH was dosed rectally. The data generated suggest that a starting dose of 7.5 mg/kg of INH is appropriate for initial TB treatment in elephants when premixed solution is administered directly into the oropharynx or rectal vault and 4 mg/kg are when INH is administered following immediate suspension from powdered form.</description><identifier>ISSN: 0140-7783</identifier><identifier>EISSN: 1365-2885</identifier><identifier>DOI: 10.1111/j.1365-2885.2004.00619.x</identifier><identifier>PMID: 15720511</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Administration, Oral ; Administration, Rectal ; Animals ; Antitubercular Agents - administration &amp; dosage ; Antitubercular Agents - blood ; Antitubercular Agents - pharmacokinetics ; Antitubercular Agents - therapeutic use ; Area Under Curve ; bacterial infections ; dosage ; drug formulations ; drug therapy ; Elephants - metabolism ; Elephas maximus ; Female ; isoniazid ; Isoniazid - administration &amp; dosage ; Isoniazid - blood ; Isoniazid - pharmacokinetics ; Isoniazid - therapeutic use ; Loxodonta africana ; Male ; Mycobacterium tuberculosis ; oral administration ; pharmacokinetics ; powders ; rectal administration ; rectum ; tuberculosis ; Tuberculosis - drug therapy ; Tuberculosis - veterinary</subject><ispartof>Journal of veterinary pharmacology and therapeutics, 2005-02, Vol.28 (1), p.21-27</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4289-3ef2206019068ea0717ef7cb615475e550a050b960e9f7c876277ed2664300953</citedby><cites>FETCH-LOGICAL-c4289-3ef2206019068ea0717ef7cb615475e550a050b960e9f7c876277ed2664300953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2885.2004.00619.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2885.2004.00619.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15720511$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maslow, J.N</creatorcontrib><creatorcontrib>Mikota, S.K</creatorcontrib><creatorcontrib>Zhu, M</creatorcontrib><creatorcontrib>Isaza, R</creatorcontrib><creatorcontrib>Peddie, L.R</creatorcontrib><creatorcontrib>Dunker, F</creatorcontrib><creatorcontrib>Peddie, J</creatorcontrib><creatorcontrib>Riddle, H</creatorcontrib><creatorcontrib>Peloquin, C.A</creatorcontrib><title>Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)</title><title>Journal of veterinary pharmacology and therapeutics</title><addtitle>J Vet Pharmacol Ther</addtitle><description>We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the pharmacokinetics (PK) of isoniazid (INH) in elephants and provide suggestions regarding initial treatment regimens. Forty-one elephants received INH daily by either oral or rectal administration with different formulations. Population PK analysis was performed using Non-linear Mixed Effect Modeling (NONMEM). Results of oral administration indicated that compared with premixed INH solution, the drug exposure was highest with a suspension prepared freshly with INH powder. When INH was concomitantly given as an admixture over food, T(max) was delayed and variability in drug absorption was significantly increased. Compared with oral administration, similar drug exposures were found when INH was dosed rectally. The data generated suggest that a starting dose of 7.5 mg/kg of INH is appropriate for initial TB treatment in elephants when premixed solution is administered directly into the oropharynx or rectal vault and 4 mg/kg are when INH is administered following immediate suspension from powdered form.</description><subject>Administration, Oral</subject><subject>Administration, Rectal</subject><subject>Animals</subject><subject>Antitubercular Agents - administration &amp; dosage</subject><subject>Antitubercular Agents - blood</subject><subject>Antitubercular Agents - pharmacokinetics</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Area Under Curve</subject><subject>bacterial infections</subject><subject>dosage</subject><subject>drug formulations</subject><subject>drug therapy</subject><subject>Elephants - metabolism</subject><subject>Elephas maximus</subject><subject>Female</subject><subject>isoniazid</subject><subject>Isoniazid - administration &amp; dosage</subject><subject>Isoniazid - blood</subject><subject>Isoniazid - pharmacokinetics</subject><subject>Isoniazid - therapeutic use</subject><subject>Loxodonta africana</subject><subject>Male</subject><subject>Mycobacterium tuberculosis</subject><subject>oral administration</subject><subject>pharmacokinetics</subject><subject>powders</subject><subject>rectal administration</subject><subject>rectum</subject><subject>tuberculosis</subject><subject>Tuberculosis - drug therapy</subject><subject>Tuberculosis - veterinary</subject><issn>0140-7783</issn><issn>1365-2885</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFu1DAQhiMEokvhFcAnBIcsYyeOE4nLqioFtEARtBwtJ5m03ib2Yjtil8fhSXE2q3LFF_-a-f4Zy3-SEApLGs-bzZJmBU9ZWfIlA8iXAAWtlrsHyeK-8TBZAM0hFaLMTpIn3m8AICspfZycUC4YcEoXyZ9Lux17FbQ1ZHur3KAae6cNBt14YjuivTVa_dYt0YaEWyTBoQoDmjB1P-0bW6smoNPjQMJYo2vG3nrtiRqsuSErr5UhyrRk1TndRI09xj0mePLq_CA9GdROD6M_YGu7s601QRE1G9Trp8mjTvUenx3v0-Tq3fn3s_fp-svFh7PVOm1yVlZphh1jUACtoChRgaACO9HUBeW54Mg5KOBQVwVgFeulKJgQ2LKiyDOAimenyct57tbZnyP6IAftG-x7ZdCOXhYiz3MhWATLGWyc9d5hJ7dOD8rtJQU55SM3copBTjHIKR95yEfuovX5ccdYD9j-Mx4DicDbGfile9z_92D58foyimhPZ7v2AXf3duXu4vMzweWPzxeyzKqvrMyEvI78i5nvlJXqxmkvr74xoNOPVDlnkP0Fyou4qA</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Maslow, J.N</creator><creator>Mikota, S.K</creator><creator>Zhu, M</creator><creator>Isaza, R</creator><creator>Peddie, L.R</creator><creator>Dunker, F</creator><creator>Peddie, J</creator><creator>Riddle, H</creator><creator>Peloquin, C.A</creator><general>Blackwell Science Ltd</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)</title><author>Maslow, J.N ; Mikota, S.K ; Zhu, M ; Isaza, R ; Peddie, L.R ; Dunker, F ; Peddie, J ; Riddle, H ; Peloquin, C.A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4289-3ef2206019068ea0717ef7cb615475e550a050b960e9f7c876277ed2664300953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Administration, Oral</topic><topic>Administration, Rectal</topic><topic>Animals</topic><topic>Antitubercular Agents - administration &amp; dosage</topic><topic>Antitubercular Agents - blood</topic><topic>Antitubercular Agents - pharmacokinetics</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Area Under Curve</topic><topic>bacterial infections</topic><topic>dosage</topic><topic>drug formulations</topic><topic>drug therapy</topic><topic>Elephants - metabolism</topic><topic>Elephas maximus</topic><topic>Female</topic><topic>isoniazid</topic><topic>Isoniazid - administration &amp; dosage</topic><topic>Isoniazid - blood</topic><topic>Isoniazid - pharmacokinetics</topic><topic>Isoniazid - therapeutic use</topic><topic>Loxodonta africana</topic><topic>Male</topic><topic>Mycobacterium tuberculosis</topic><topic>oral administration</topic><topic>pharmacokinetics</topic><topic>powders</topic><topic>rectal administration</topic><topic>rectum</topic><topic>tuberculosis</topic><topic>Tuberculosis - drug therapy</topic><topic>Tuberculosis - veterinary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maslow, J.N</creatorcontrib><creatorcontrib>Mikota, S.K</creatorcontrib><creatorcontrib>Zhu, M</creatorcontrib><creatorcontrib>Isaza, R</creatorcontrib><creatorcontrib>Peddie, L.R</creatorcontrib><creatorcontrib>Dunker, F</creatorcontrib><creatorcontrib>Peddie, J</creatorcontrib><creatorcontrib>Riddle, H</creatorcontrib><creatorcontrib>Peloquin, C.A</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maslow, J.N</au><au>Mikota, S.K</au><au>Zhu, M</au><au>Isaza, R</au><au>Peddie, L.R</au><au>Dunker, F</au><au>Peddie, J</au><au>Riddle, H</au><au>Peloquin, C.A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)</atitle><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle><addtitle>J Vet Pharmacol Ther</addtitle><date>2005-02</date><risdate>2005</risdate><volume>28</volume><issue>1</issue><spage>21</spage><epage>27</epage><pages>21-27</pages><issn>0140-7783</issn><eissn>1365-2885</eissn><abstract>We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the pharmacokinetics (PK) of isoniazid (INH) in elephants and provide suggestions regarding initial treatment regimens. Forty-one elephants received INH daily by either oral or rectal administration with different formulations. Population PK analysis was performed using Non-linear Mixed Effect Modeling (NONMEM). Results of oral administration indicated that compared with premixed INH solution, the drug exposure was highest with a suspension prepared freshly with INH powder. When INH was concomitantly given as an admixture over food, T(max) was delayed and variability in drug absorption was significantly increased. Compared with oral administration, similar drug exposures were found when INH was dosed rectally. The data generated suggest that a starting dose of 7.5 mg/kg of INH is appropriate for initial TB treatment in elephants when premixed solution is administered directly into the oropharynx or rectal vault and 4 mg/kg are when INH is administered following immediate suspension from powdered form.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>15720511</pmid><doi>10.1111/j.1365-2885.2004.00619.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-7783
ispartof Journal of veterinary pharmacology and therapeutics, 2005-02, Vol.28 (1), p.21-27
issn 0140-7783
1365-2885
language eng
recordid cdi_proquest_miscellaneous_67444772
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Administration, Oral
Administration, Rectal
Animals
Antitubercular Agents - administration & dosage
Antitubercular Agents - blood
Antitubercular Agents - pharmacokinetics
Antitubercular Agents - therapeutic use
Area Under Curve
bacterial infections
dosage
drug formulations
drug therapy
Elephants - metabolism
Elephas maximus
Female
isoniazid
Isoniazid - administration & dosage
Isoniazid - blood
Isoniazid - pharmacokinetics
Isoniazid - therapeutic use
Loxodonta africana
Male
Mycobacterium tuberculosis
oral administration
pharmacokinetics
powders
rectal administration
rectum
tuberculosis
Tuberculosis - drug therapy
Tuberculosis - veterinary
title Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T11%3A39%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Population%20pharmacokinetics%20of%20isoniazid%20in%20the%20treatment%20of%20Mycobacterium%20tuberculosis%20among%20Asian%20and%20African%20elephants%20(Elephas%20maximus%20and%20Loxodonta%20africana)&rft.jtitle=Journal%20of%20veterinary%20pharmacology%20and%20therapeutics&rft.au=Maslow,%20J.N&rft.date=2005-02&rft.volume=28&rft.issue=1&rft.spage=21&rft.epage=27&rft.pages=21-27&rft.issn=0140-7783&rft.eissn=1365-2885&rft_id=info:doi/10.1111/j.1365-2885.2004.00619.x&rft_dat=%3Cproquest_cross%3E67444772%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67444772&rft_id=info:pmid/15720511&rfr_iscdi=true